Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
32 hedge funds and large institutions have $5.61M invested in Zosano Pharma Corporation in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 7 closing their positions.
0% more funds holding
Funds holding: 32 → 32 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
38% less capital invested
Capital invested by funds: $8.98M → $5.61M (-$3.37M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
+$44.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$39.3K |
| 3 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
+$24.1K |
| 4 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
+$24.1K |
| 5 |
Morgan Stanley
New York
|
+$22.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$303K |
| 2 |
Renaissance Technologies
New York
|
-$172K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$105K |
| 4 |
N
Natixis
Paris,
France
|
-$21K |
| 5 |
TI
Telemetry Investments
New York
|
-$13.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCIA
26
Prime Capital Investment Advisors
Overland Park,
Kansas
| $6K | – | – | – |
|
|
AAS
27
Avantax Advisory Services
Dallas,
Texas
| $5K | – | – | – |
|
|
JSW
28
Journey Strategic Wealth
Summit,
New Jersey
| $5K | +$6.04K | +286 | New |
|
|
EC
29
Estate Counselors
Thiensville,
Wisconsin
| $2K | – | – | – |
|
30
Wells Fargo
San Francisco,
California
| $1K | +$42 | +2 | +4% |
|
|
TWC
31
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $3 | – | – | – |
|
|
GCP
32
GSA Capital Partners
London,
United Kingdom
| – | -$303K | -12,044 | Closed |
|
|
33
Renaissance Technologies
New York
| – | -$172K | -6,822 | Closed |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$105K | -4,176 | Closed |
|
|
N
35
Natixis
Paris,
France
| – | -$21K | -849 | Closed |
|
|
GRP
36
Global Retirement Partners
San Rafael,
California
| – | -$1K | -36 | Closed |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$148 | -7 | -64% |
|
|
CDIA
38
Capital Directions Investment Advisors
Atlanta,
Georgia
| – | -$13K | -1 | Closed |
|
|
FWM
39
Focused Wealth Management
Newburgh,
New York
| – | +$232 | +11 | New |
|
ZSAN Hedge Fund Activity: Q4 2021 in Review
32 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q4 2021, worth a combined $5.61M — down 38% from $8.98M a quarter earlier.
Fund positioning in ZSAN was balanced in Q4 2021: 7 funds opened new positions, 7 closed out, 6 added to existing stakes and 7 trimmed.
The largest buyer was StoneX Group, opening a new position worth an estimated $44.1K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $303K sold.
- 32 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $5.61M of Zosano Pharma Corporation stock for Q4 2021, down 38% quarter-over-quarter.
- 7 funds opened new Zosano Pharma Corporation positions in Q4 2021 and 7 closed out, a net change of 0 holders.
- The largest Zosano Pharma Corporation buyer in Q4 2021 was StoneX Group, an estimated $44.1K added.
- The largest Zosano Pharma Corporation seller in Q4 2021 was GSA Capital Partners, an estimated $303K sold.
Based on aggregated 13F filings for Q4 2021.